blood cancers
| 4 min read
LYMPHIR delivers targeted therapy for a rare and incurable form of skin lymphoma while opening doors for broader immuno-oncology applications.
| 3 min read
QDX and Prelude Therapeutics are developing drugs that selectively target the JAK2 V617F mutation, offering hope for patients with myeloproliferative neoplasms.
| 4 min read
New results from an anti-seizure medication and blood cancer drug, a new AI platform, and a novel heart disease drug led drug discovery this week.
| 3 min read
A blood test for organ rejection, another death related to gene therapy for Duchenne muscular dystrophy, a setback for AbbVie, and more led the news this week.
| 9 min read
This year’s Breakthrough Prizes honor advances in CAR T cancer therapies, cystic fibrosis, and Parkinson’s disease.
Page 1 of 1 - 5 Total Items
